about
What causes in vivo muscle specific tension to increase following resistance training?The adaptations to strength training : morphological and neurological contributions to increased strength.The FTO A/T polymorphism and elite athletic performance: a study involving three groups of European athletes.Variation in the uncoupling protein 2 and 3 genes and human performance.Fat mass and obesity associated (FTO) gene influences skeletal muscle phenotypes in non-resistance trained males and elite rugby playing positionDirect-to-consumer genetic testing for predicting sports performance and talent identification: Consensus statementAthlome Project Consortium: a concerted effort to discover genomic and other "omic" markers of athletic performance.Association of ACTN3 R577X but not ACE I/D gene variants with elite rugby union player status and playing position.Gene polymorphisms and fiber-type composition of human skeletal muscle.Genomics of elite sporting performance: what little we know and necessary advances.Genomics in rugby union: A review and future prospects.The Future of Genomic Research in Athletic Performance and Adaptation to Training.Genetics of muscle strength and power: polygenic profile similarity limits skeletal muscle performance.Medial gastrocnemius specific force of adult men with spastic cerebral palsy.The individual and combined influence of ACE and ACTN3 genotypes on muscle phenotypes before and after strength training.Muscle size, activation, and coactivation in adults with cerebral palsy.Effects of resistance exercise volume and nutritional supplementation on anabolic and catabolic hormones.Variability and distribution of muscle strength and its determinants in humans.Inter-individual variability in the adaptation of human muscle specific tension to progressive resistance training.The HIF1A gene Pro582Ser polymorphism in Russian strength athletes.COL5A1 gene variants previously associated with reduced soft tissue injury risk are associated with elite athlete status in rugby.No association between ACTN3 R577X and ACE I/D polymorphisms and endurance running times in 698 Caucasian athletes.Training diagnosis for a load carriage task.Allometric scaling of strength measurements to body size.Bradykinin receptor gene variant and human physical performance.TTN genotype is associated with fascicle length and marathon running performance.Passive stiffness of the gastrocnemius muscle in athletes with spastic hemiplegic cerebral palsy.Similarity of polygenic profiles limits the potential for elite human physical performance.Polymorphisms in PTK2 are associated with skeletal muscle specific force: an independent replication study.Association of the VEGFR2 gene His472Gln polymorphism with endurance-related phenotypes.No correlation between circulating ACE activity and VO2max or mechanical efficiency in women.The training stimulus experienced by the leg muscles during cycling in humans.Simple anthropometric and physical performance tests to predict maximal box-lifting ability.Human COL5A1 rs12722 gene polymorphism and tendon properties in vivo in an asymptomatic population.Resistance training and the enhancement of the gains in material-handling ability and physical fitness of British Army recruits during basic training.Do PTK2 gene polymorphisms contribute to the interindividual variability in muscle strength and the response to resistance training? A preliminary report.The combined impact of metabolic gene polymorphisms on elite endurance athlete status and related phenotypesEndurance enhancement related to the human angiotensin I-converting enzyme I-D polymorphism is not due to differences in the cardiorespiratory response to trainingThe ACE gene and muscle performanceErratum to: Variants within the MMP3 gene and patellar tendon properties in vivo in an asymptomatic population
P50
Q28294706-983DF123-567D-45FC-B090-8CA11CB0A28CQ34604752-04CDA9C6-CD46-450C-B925-594896E54173Q34662035-8CF7F102-B9DE-4AAC-9E27-D0FE5654B357Q35901054-2D7AF4A4-1CFE-45DC-A9C2-1F7A5DFBEBFDQ36254346-6476801B-637C-47F0-8A80-D135FF94C7A2Q36374715-F5D919F1-7699-4129-AD13-C173579E595DQ36638635-37506697-5415-4935-AC51-B11483E90725Q37056953-075CC091-2BA7-4D60-9EC0-FA150D8DE7C2Q38014392-FB143CA8-4CE3-43AD-A78F-4950D8C09558Q38164859-F8A5AD01-BBFD-418C-9D88-0BE38E2FA435Q38387697-EBE932AC-3A59-480F-BA7C-E80AE4D38462Q38855015-BC5456F6-9E19-4E22-AD36-FDB531B39898Q39714368-EAC693D2-8809-46AA-AD2C-15CD391CE220Q41540105-142780DC-1B61-4B57-B3BF-152CEB4D6D63Q43431359-EF4870EC-73B5-4C16-BDBC-4C4A57467D7CQ43581291-295DA292-FD83-4023-AE43-81A2208213EDQ43980147-31E597CD-A67D-4D8F-90B5-39EC2199C3ECQ44669402-90F7BE8C-8A50-4714-8FD8-7716E66A18E0Q44970800-AF198647-2049-4A89-AD5F-CEEF536B3F17Q45364113-C4035763-D151-4F53-BB54-D4442C3C15BDQ47128009-1F14405D-F6C6-40F3-865E-C04DCF96D081Q47144310-2270C5DE-FDF7-4F25-B2EE-774110CE2806Q47198529-6FCA050D-283A-4DD8-9C0D-0EDBF1640D62Q47253867-FF54F284-C081-4F38-8F95-568C433B404FQ47395292-17123497-80FF-4EBC-9F45-1F7555C0B49DQ48328022-3BD8CBDD-1A3E-48F2-BE5E-39068A86D41CQ50480241-78C711EF-8661-4D85-A54E-8F6B740E6492Q50529684-C5A9EF3E-1434-4E61-97CB-2DA3C33C095BQ50866086-79F7DE3D-9CAE-4C3B-B5CB-BF7CE388EBB0Q51632500-D6CFCB16-88D2-480B-B021-90060C59E50EQ51784029-80CBA588-5796-4DBB-B11C-42AD0C54F2CAQ51820455-7D785603-0126-44DB-8C29-AE103F18AC13Q51913761-1F9033AC-8AC6-4FC1-A49A-9BC942556689Q53595481-F02A768A-8CDD-4959-9A01-50F724EF4954Q53970025-FB7410B1-24A5-4D26-8A5C-6353CA4658CCQ54530578-5139FA3C-842A-40A5-B3BA-5686F0D12EA9Q57243036-824D2DEA-1F5A-44DD-B5B1-813A02DA2528Q57243089-ED975B30-A207-42C9-96CA-823C1EB80FBFQ57243110-699A10E0-D4ED-48F6-A979-EAC2DC407AB4Q57925008-BF49ECF7-08A2-432B-BC78-4BF102FF350C
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Alun G Williams
@es
Alun G. Williams
@en
Alun G. Williams
@nl
type
label
Alun G Williams
@es
Alun G. Williams
@en
Alun G. Williams
@nl
prefLabel
Alun G Williams
@es
Alun G. Williams
@en
Alun G. Williams
@nl
P106
P1153
24377146500
P21
P31
P496
0000-0002-8052-8184
P569
2000-01-01T00:00:00Z